sorafenib has been researched along with hts 466284 in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (hts 466284) | Trials (hts 466284) | Recent Studies (post-2010) (hts 466284) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 43 | 0 | 27 |
| Protein | Taxonomy | sorafenib (IC50) | hts 466284 (IC50) |
|---|---|---|---|
| Chain A, TGF-beta receptor type I | Homo sapiens (human) | 0.051 | |
| Chain A, TGF-beta receptor type I | Homo sapiens (human) | 0.051 | |
| TGF-beta receptor type-1 | Homo sapiens (human) | 0.0522 | |
| TGF-beta receptor type-2 | Homo sapiens (human) | 0.4 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.74 | |
| Mitogen-activated protein kinase kinase kinase 20 | Homo sapiens (human) | 1.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwata, C; Kano, MR; Kataoka, K; Komuta, Y; Miyazono, K; Morishita, Y; Oka, M; Ouchi, Y; Shirai, YT | 1 |
1 other study(ies) available for sorafenib and hts 466284
| Article | Year |
|---|---|
Comparison of the effects of the kinase inhibitors imatinib, sorafenib, and transforming growth factor-beta receptor inhibitor on extravasation of nanoparticles from neovasculature.
Topics: Animals; Benzamides; Benzenesulfonates; Cell Line, Tumor; Extravasation of Diagnostic and Therapeutic Materials; Humans; Imatinib Mesylate; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Receptors, Transforming Growth Factor beta; Signal Transduction; Sorafenib; Vascular Endothelial Growth Factor A | 2009 |